Publications 2020

Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK, GARFIELD-AF Investigators (2020)
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
Europace, 22 (2), 195-204
DOI 10.1093/europace/euz292, PubMed 31747004

Cadilhac DA, Kim J, Wilson A, Berge E, Patel A, Ali M, Saver J, Christensen H, Cuche M, Crews S, Wu O, Provoyeur M, McMeekin P, Durand-Zaleski I, Ford GA, Muhlemann N, Bath PM, Abdul-Rahim AH, Sunnerhagen K, Meretoja A, Thijs V, Weimar C, Massaro A, Ranta A, Lees KR et al. (2020)
Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group
Eur Stroke J, 5 (2), 184-192
DOI 10.1177/2396987319897466, PubMed 32637652

Godolphin PJ, Bath PM, Algra A, Berge E, Chalmers J, Eliasziw M, Hankey GJ, Hosomi N, Ranta A, Weimar C, Woodhouse LJ, Montgomery AA (2020)
Cost-benefit of outcome adjudication in nine randomised stroke trials
Clin Trials, 17 (5), 576-580
DOI 10.1177/1740774520939231, PubMed 32650688

Godolphin PJ, Bath PM, Partlett C, Berge E, Brown MM, Eliasziw M, Sandset PM, Serena J, Montgomery AA (2020)
Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification
Eur Stroke J, 5 (2), 174-183
DOI 10.1177/2396987320910047, PubMed 32637651

Larsen KT, Forfang E, Pennlert J, Glader EL, Kruuse C, Wester P, Ihle-Hansen H, Carlsson M, Berge E, Salman RA, Wyller TB, Ronning OM (2020)
STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage: Protocol for a randomised controlled trial
Eur. Stroke J., 5 (4), 2396987320954671-422

Malhotra K, Katsanos AH, Goyal N, Tayal A, Gensicke H, Mitsias PD, De Marchis GM, Berge E, Alexandrov AW, Alexandrov AV, Tsivgoulis G (2020)
Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis
Neurology, 95 (2), e121-e130
DOI 10.1212/WNL.0000000000009756, PubMed 32554767

Mehlum MH, Liestøl K, Kjeldsen SE, Wyller TB, Julius S, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E (2020)
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers
Hypertension, 75 (6), 1584-1592
DOI 10.1161/HYPERTENSIONAHA.119.14443, PubMed 32336236

Mh Bruins Slot K, Berge E (2020)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolismin patients with atrial fibrillation
Emergencias, 32 (4), 278-279
PubMed 32692005

Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Kjeldsen S, Grundvold I, Berge E (2020)
Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men
Stroke, 51 (5), 1435-1441
DOI 10.1161/STROKEAHA.119.027233, PubMed 32268850

Rudberg AS, Berge E, Laska AC, Jutterström S, Näsman P, Sunnerhagen KS, Lundström E (2020)
Stroke survivors' priorities for research related to life after stroke
Top Stroke Rehabil
DOI 10.1080/10749357.2020.1789829, PubMed 32627722

Slot KMHB, Berge E (2020)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolismin patients with atrial fibrillation
Emergencias, 32 (4), 278-279

Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A (2020)
Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise
Clin Biochem (in press)
DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871

Wang X, Moullaali TJ, Li Q, Berge E, Robinson TG, Lindley R, Zheng D, Delcourt C, Arima H, Song L, Chen X, Yang J, Chalmers J, Anderson CS, Sandset EC (2020)
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients
Stroke, 51 (8), 2411-2417
DOI 10.1161/STROKEAHA.119.028523, PubMed 32640944

Publications 2019

Ahmed N, Audebert H, Turc G, Cordonnier C, Christensen H, Sacco S, Sandset EC, Ntaios G, Charidimou A, Toni D, Pristipino C, Köhrmann M, Kuramatsu JB, Thomalla G, Mikulik R, Ford GA, Martí-Fàbregas J, Fischer U, Thoren M, Lundström E, Rinkel GJ, van der Worp HB, Matusevicius M, Tsivgoulis G, Milionis H et al. (2019)
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018
Eur Stroke J, 4 (4), 307-317
DOI 10.1177/2396987319863606, PubMed 31903429

Appleton JP, Woodhouse LJ, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V, Christensen HK, Dineen RA, Gommans J, Koumellis P, Szatmari S, Sprigg N, Bath PM, Wardlaw JM, ENOS Investigators (2019)
Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke
Neurology, 94 (5), e439-e452
DOI 10.1212/WNL.0000000000008881, PubMed 31882527

Appleton JP, Woodhouse LJ, Belcher A, Bereczki D, Berge E, Caso V, Chang HM, Christensen HK, Collins R, Gommans J, Laska AC, Ntaios G, Ozturk S, Sare GM, Szatmari S, Wang Y, Wardlaw JM, Sprigg N, Bath PM (2019)
It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis
Stroke Vasc Neurol, 4 (1), 28-35
DOI 10.1136/svn-2019-000232, PubMed 31105976

Appleton JP, Woodhouse LJ, Bereczki D, Berge E, Christensen HK, Collins R, Gommans J, Ntaios G, Ozturk S, Szatmari S, Wardlaw JM, Sprigg N, Rothwell PM, Bath PM, ENOS Investigators (2019)
Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke
Stroke, 50 (2), 405-412
DOI 10.1161/STROKEAHA.118.023190, PubMed 30626285

Bath PM, Woodhouse LJ, Krishnan K, Appleton JP, Anderson CS, Berge E, Cala L, Dixon M, England TJ, Godolphin PJ, Hepburn T, Mair G, Montgomery AA, Phillips SJ, Potter J, Price CI, Randall M, Robinson TG, Roffe C, Rothwell PM, Sandset EC, Sanossian N, Saver JL, Siriwardena AN, Venables G et al. (2019)
Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial
Stroke, 50 (11), 3064-3071
DOI 10.1161/STROKEAHA.119.026389, PubMed 31587658

Carcel C, Wang X, Sandset EC, Delcourt C, Arima H, Lindley R, Hackett ML, Lavados P, Robinson TG, Muñoz Venturelli P, Olavarría VV, Brunser A, Berge E, Chalmers J, Woodward M, Anderson CS (2019)
Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants
Neurology, 93 (24), e2170-e2180
DOI 10.1212/WNL.0000000000008615, PubMed 31719135

Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
Int J Cardiol, 287, 1-6
DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595

Godolphin PJ, Bath PM, Algra A, Berge E, Brown MM, Chalmers J, Duley L, Eliasziw M, Gregson J, Greving JP, Hankey GJ, Hosomi N, Johnston SC, Patsko E, Ranta A, Sandset PM, Serena J, Weimar C, Montgomery AA, Knipp SC, Giugliano RP, Bonati LH, Nagai Y, Matsumoto M, Barnett HJM et al. (2019)
Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis
Stroke, 50 (8), 2187-2196

Jusufovic M, Berge TE, Guo R, You S, Delcourt C, Anderson C, Bath PM, Karlson BW, Berge E, Sandset EC, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2019)
Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage
J Stroke Cerebrovasc Dis, 28 (8), 2262-2267
DOI 10.1016/j.jstrokecerebrovasdis.2019.05.010, PubMed 31178359

Kelly P, Salman RA, Arsovska A, Dippel DW, Fischer U, Ford GA, Fuentes B, Lemmens R, Marshall JC, Nederkoorn PJ, Robinson T, Weimar C, Berge E, ESO Trials Network Committee ESOTA Steering Group (2019)
Building a European 'network of networks' for stroke clinical research - The European Stroke Organisation Trials Alliance (ESOTA)
Eur Stroke J, 4 (3), 224-232
DOI 10.1177/2396987319845589, PubMed 31984229

Klijn CJ, Paciaroni M, Berge E, Korompoki E, Kõrv J, Lal A, Putaala J, Werring DJ (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Eur Stroke J, 4 (3), 198-223
DOI 10.1177/2396987319841187, PubMed 31984228

Lindekleiv H, Slot KMHB, Wardlaw JM, Berge E (2019)
Percutaneous Vascular Interventions Versus Intravenous Thrombolytic Treatment for Acute Ischemic Stroke
Stroke, 50 (5), E119-E120

Mariampillai JE, Liestøl K, Kjeldsen SE, Prestgaard EE, Engeseth K, Bodegard J, Berge E, Gjesdal K, Erikssen J, Grundvold I, Skretteberg PT (2019)
Exercise Systolic Blood Pressure at Moderate Workload Is Linearly Associated With Coronary Disease Risk in Healthy Men
Hypertension, 75 (1), 44-50
DOI 10.1161/HYPERTENSIONAHA.119.13528, PubMed 31735088

Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2019)
SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
J Hypertens, 37 (5), 949-955
DOI 10.1097/HJH.0000000000001959, PubMed 30325341

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E (2019)
Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial
Blood Press, 28 (2), 77-83
DOI 10.1080/08037051.2018.1524707, PubMed 30614275

Moullaali TJ, Wang X, Woodhouse LJ, Law ZK, Delcourt C, Sprigg N, Krishnan K, Robinson TG, Wardlaw JM, Al-Shahi Salman R, Berge E, Sandset EC, Anderson CS, Bath PM, BASC Investigators (2019)
Lowering blood pressure after acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis using individual patient data from randomised controlled trials participating in the Blood Pressure in Acute Stroke Collaboration (BASC)
BMJ Open, 9 (7), e030121
DOI 10.1136/bmjopen-2019-030121, PubMed 31315876

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists’ Collaboration (2019)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
J Hypertens, 37 (1), 16-23
DOI 10.1097/HJH.0000000000001994, PubMed 30499920

Sandset EC, Appleton JP, Berge E, Christensen H, Gommans J, Krishnan K, Ntaios G, Phillips S, Pocock S, Sprigg N, Woodhouse LJ, Bath PM, ENOS trial investigators* (2019)
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial
J Hypertens, 37 (10), 2104-2109
DOI 10.1097/HJH.0000000000002154, PubMed 31246895

Publications 2018

Bendszus M, Bonekamp S, Berge E, Boutitie F, Brouwer P, Gizewski E, Krajina A, Pierot L, Randall G, Simonsen CZ, Zeleňák K, Fiehler J, Thomalla G (2018)
A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window
Int J Stroke, 14 (1), 87-93
DOI 10.1177/1747493018798558, PubMed 30156479

Billington CK, Appleton JP, Berge E, Sprigg N, Glover M, Bath PMW (2018)
Impact of hydration status on haemodynamics, effects of acute blood pressure-lowering treatment, and prognosis after stroke
Br J Clin Pharmacol, 84 (12), 2914-2922
DOI 10.1111/bcp.13761, PubMed 30194849

Bruins Slot KM, Berge E (2018)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev, 3, CD008980
DOI 10.1002/14651858.CD008980.pub3, PubMed 29509959

Ciccone A, Berge E, Fischer U (2018)
Systematic review of organizational models for intra-arterial treatment of acute ischemic stroke
Int J Stroke, 14 (1), 12-22
DOI 10.1177/1747493018806157, PubMed 30303811

Coutts SB, Berge E, Campbell BC, Muir KW, Parsons MW (2018)
Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials
Int J Stroke, 13 (9), 885-892
DOI 10.1177/1747493018790024, PubMed 30035698

Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
Cytokine, 105, 17-22
DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015

Godolphin PJ, Hepburn T, Sprigg N, Walker L, Berge E, Collins R, Gommans J, Ntaios G, Pocock S, Prasad K, Wardlaw JM, Bath PM, Montgomery AA (2018)
Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation
Contemp Clin Trials Commun, 12, 176-181
DOI 10.1016/j.conctc.2018.11.002, PubMed 30533551

Godolphin PJ, Montgomery AA, Woodhouse LJ, Bereczki D, Berge E, Collins R, Díez-Tejedor E, Gommans J, Lees KR, Ozturk S, Phillips S, Pocock S, Prasad K, Szatmari S, Wang Y, Bath PM, Sprigg N, ENOS Investigators (2018)
Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial
PLoS One, 13 (11), e0208142
DOI 10.1371/journal.pone.0208142, PubMed 30475912

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J, Blood Pressure Lowering Treatment Trialists’ Collaboration (2018)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
PLoS Med, 15 (3), e1002538
DOI 10.1371/journal.pmed.1002538, PubMed 29558462

Lindekleiv H, Berge E, Bruins Slot KM, Wardlaw JM (2018)
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke
Cochrane Database Syst Rev, 10, CD009292
DOI 10.1002/14651858.CD009292.pub2, PubMed 30365156

Mehlum MH, Liestøl K, Kjeldsen SE, Berge E (2018)
Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues
Eur Heart J, 39 (47), 4221
DOI 10.1093/eurheartj/ehy605, PubMed 30496492

Mehlum MH, Liestøl K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, Mancia G, Parati G, Weber MA, Berge E (2018)
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
Eur Heart J, 39 (24), 2243-2251
DOI 10.1093/eurheartj/ehx760, PubMed 29365085

Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E (2018)
Change in Cardiorespiratory Fitness and Risk of Stroke and Death
Stroke, 50 (1), 155-161
DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727

Reinink H, de Jonge JC, Bath PM, van de Beek D, Berge E, Borregaard S, Ciccone A, Csiba L, Demotes J, Dippel DW, Kõrv J, Kurkowska-Jastrzebska I, Lees KR, Macleod MR, Ntaios G, Randall G, Thomalla G, van der Worp HB (2018)
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment
Eur Stroke J, 3 (3), 291-298
DOI 10.1177/2396987318772687, PubMed 30246150

Roaldsen MB, Lindekleiv H, Mathiesen EB, Berge E (2018)
Recanalisation therapies for wake-up stroke
Cochrane Database Syst Rev, 8, CD010995
DOI 10.1002/14651858.CD010995.pub2, PubMed 30129656

Rudberg AS, Berge E, Gustavsson A, Näsman P, Lundström E (2018)
Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke
Eur Stroke J, 3 (2), 157-164
DOI 10.1177/2396987317753444, PubMed 31008347

Sandset EC, Sanossian N, Woodhouse LJ, Anderson C, Berge E, Lees KR, Potter JF, Robinson TG, Sprigg N, Wardlaw JM, Bath PM, Blood pressure in Acute Stroke Collaboration Investigators (2018)
Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3
Int J Stroke, 13 (7), 759-765
DOI 10.1177/1747493018772733, PubMed 29720045

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G et al. (2018)
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
Ann Neurol, 83 (3), 451-459
DOI 10.1002/ana.25165, PubMed 29394504

Slot KMHB, Berge E (2018)
Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Stroke, 49 (7), E235-E236

Publications 2017

Barer D, Berge E (2017)
Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data?
Drugs Aging, 34 (2), 79-88
DOI 10.1007/s40266-016-0432-8, PubMed 28120326

Berge E (2017)
Should elevated blood pressure be lowered in the acute phase of ischaemic stroke?
J Hypertens, 35 (6), 1166-1167
DOI 10.1097/HJH.0000000000001338, PubMed 28441257

Berge E, Al-Shahi Salman R, van der Worp HB, Stapf C, Sandercock P, Sprigg N, Macleod MR, Kelly PJ, Nederkoorn PJ, Ford GA, European Stroke Organisation Trials Network Committee (2017)
Increasing value and reducing waste in stroke research
Lancet Neurol, 16 (5), 399-408
DOI 10.1016/S1474-4422(17)30078-9, PubMed 28414653

Berge E, Ford GA, Stapf C, Al-Shahi Salman R, Fischer U, Coveney S, Weimar C, Arnold M, Arsovska A, Lemmens R, Nederkoorn PJ, Kelly PJ (2017)
Are there opportunities for a closer collaboration on clinical stroke research in Europe?
Eur Stroke J, 3 (1), 22-28
DOI 10.1177/2396987317747456, PubMed 31008334

Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
Pro-coagulant activity during exercise testing in patients with coronary artery disease
Thromb J, 15, 3
DOI 10.1186/s12959-016-0127-8, PubMed 28115916

Dickie DA, Aribisala B, Mair G, Berge E, Lindley RI, Sandercock P, von Kummer R, von Heijne A, Peeters A, Cala L, Farrall A, Morris Z, Bradey N, Potter G, Adami A, Wardlaw JM (2017)
Blood pressure variability and leukoaraiosis in acute ischemic stroke
Int J Stroke, 13 (5), 473-480
DOI 10.1177/1747493017729267, PubMed 28872448

Krishnan K, Beishon L, Berge E, Christensen H, Dineen RA, Ozturk S, Sprigg N, Wardlaw JM, Bath PM, VISTA-ICH collaboration and ENOS Investigators (2017)
Relationship between race and outcome in Asian, Black, and Caucasian patients with spontaneous intracerebral hemorrhage: Data from the Virtual International Stroke Trials Archive and Efficacy of Nitric Oxide in Stroke trial
Int J Stroke, 13 (4), 362-373
DOI 10.1177/1747493017744463, PubMed 29165060

Learoyd AE, Woodhouse L, Shaw L, Sprigg N, Bereczki D, Berge E, Caso V, Christensen H, Collins R, Czlonkowska A, El Etribi A, Farr TD, Gommans J, Laska AC, Ntaios G, Ozturk S, Pocock SJ, Prasad K, Wardlaw JM, Fone KC, Bath PM, Trueman RC, ENOS Trial investigators (2017)
Infections Up to 76 Days After Stroke Increase Disability and Death
Transl Stroke Res, 8 (6), 541-548
DOI 10.1007/s12975-017-0553-3, PubMed 28752410

Liang Y, Deng M, Chen YK, Mok V, Wang DF, Ungvari GS, Chu CW, Berge E, Tang WK (2017)
Enlarged perivascular spaces are associated with health-related quality of life in patients with acute ischemic stroke
CNS Neurosci Ther, 23 (12), 973-979
DOI 10.1111/cns.12766, PubMed 29052954

Perry LA, Berge E, Bowditch J, Forfang E, Rønning OM, Hankey GJ, Villanueva E, Al-Shahi Salman R (2017)
Antithrombotic treatment after stroke due to intracerebral haemorrhage
Cochrane Database Syst Rev, 5, CD012144
DOI 10.1002/14651858.CD012144.pub2, PubMed 28540976

Perry LA, Berge E, Bowditch J, Forfang E, Ronning OM, Hankey GJ, Villanueva E, Salman RA (2017)
Antithrombotic Treatment After Stroke Because Of Intracerebral Hemorrhage
Stroke, 48 (9), E247

Pollock A, Berge E (2017)
How to do a systematic review
Int J Stroke, 13 (2), 138-156
DOI 10.1177/1747493017743796, PubMed 29148960

Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
Long-term predictors of stroke in healthy middle-aged men
Int J Stroke, 13 (3), 292-300
DOI 10.1177/1747493017730760, PubMed 28929941

Woodhouse LJ, Manning L, Potter JF, Berge E, Sprigg N, Wardlaw J, Lees KR, Bath PM, Robinson TG, Blood Pressure in Acute Stroke Collaboration (2017)
Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke: An Individual Patient Data Meta-Analysis
Hypertension, 69 (5), 933-941
DOI 10.1161/HYPERTENSIONAHA.116.07982, PubMed 28264916

Woodhouse LJ, Scutt P, Hamdy S, Smithard DG, Cohen DL, Roffe C, Bereczki D, Berge E, Bladin CF, Caso V, Christensen HK, Collins R, Czlonkowska A, de Silva A, Etribi A, Laska AC, Ntaios G, Ozturk S, Phillips SJ, Prasad K, Szatmari S, Sprigg N, Bath PM (2017)
Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial
Transl Stroke Res, 9 (2), 120-129
DOI 10.1007/s12975-017-0548-0, PubMed 28770403

Publications 2016

Bath PM, Woodhouse L, Krishnan K, Anderson C, Berge E, Ford GA, Robinson TG, Saver JL, Sprigg N, Wardlaw JM, In Acute Stroke Collaboration Basc BP (2016)
Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials
Stroke Res Treat, 2016, 9706720
DOI 10.1155/2016/9706720, PubMed 27190674

Berge E, Cohen G, Roaldsen MB, Lundström E, Isaksson E, Rudberg AS, Slot KB, Forbes J, Smith J, Drever J, Wardlaw JM, Lindley RI, Sandercock PA, Whiteley WN, IST-3 Collaborative Group (2016)
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
Lancet Neurol, 15 (10), 1028-34
DOI 10.1016/S1474-4422(16)30139-9, PubMed 27450474

Berge E, Cohen G, Wardlaw JM, Sandercock PAG, Whiteley WN (2016)
Mortality after thrombolysis - Authors' reply
Lancet Neurol, 15 (13), 1305
DOI 10.1016/S1474-4422(16)30280-0, PubMed 27839642

Berge E, Stapf C, Al-Shahi Salman R, Ford GA, Sandercock P, van der Worp HB, Petersson J, Dippel DW, Krieger DW, Lees KR, ESO Trials Network Committee (2016)
Methods to improve patient recruitment and retention in stroke trials
Int J Stroke, 11 (6), 663-76
DOI 10.1177/1747493016641963, PubMed 27118766

Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, Cools F, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Koretsune Y, Mantovani LG, Misselwitz F, Oh S, Turpie AG, Verheugt FW, Kakkar AK, GARFIELD-AF Investigators (2016)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, 103 (4), 307-314
DOI 10.1136/heartjnl-2016-309832, PubMed 27647168

Jusufovic M, Mishra NK, Lansberg MG, Bath PM, Berge E, Sandset EC (2016)
Blood Pressure Management in Acute Stroke
Curr Hypertens Rev, 12 (2), 121-6
DOI 10.2174/1573402112666160302102711, PubMed 26931471

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2016)
Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST)
J Hypertens, 34 (8), 1594-8
DOI 10.1097/HJH.0000000000000980, PubMed 27228435

Wilson A, Bath PM, Berge E, Cadilhac DA, Cuche M, Ford GA, Macisaac R, Quinn TJ, Taylor M, Walters M, Wolff C, Lees KR, for the ESO-VISTA Health Economics Working Group (2016)
Understanding the relationship between costs and the modified Rankin Scale: A systematic review, multidisciplinary consensus and recommendations for future studies
Eur Stroke J, 2 (1), 3-12
DOI 10.1177/2396987316684705, PubMed 29900405

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D et al. (2016)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke
J Hypertens, 34 (3), 393-6
DOI 10.1097/HJH.0000000000000853, PubMed 26780185

Publications 2015

Berge E (2015)
Increased life expectancy for physically active Norwegians
Br J Sports Med, 49 (11), 702
DOI 10.1136/bjsports-2015-094867, PubMed 25979921

Berge E (2015)
Blood pressure-lowering treatment in acute intracerebral haemorrhage
J Hypertens, 33 (5), 931-2
DOI 10.1097/HJH.0000000000000537, PubMed 25909696

Berge E, Cohen G, Lindley RI, Sandercock P, Wardlaw JM, Sandset EC, Whiteley W (2015)
Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke
Stroke, 46 (12), 3362-9
DOI 10.1161/STROKEAHA.115.010319, PubMed 26486868

Berge E, Ford GA, Bath PM, Stapf C, van der Worp HB, Demotes J, Broderick J, Al-Shahi Salman R, Lees KR, ESO Trials Network Committee (2015)
Regulation and governance of multinational drug trials in stroke: barriers and possibilities
Int J Stroke, 10 (3), 425-8
DOI 10.1111/ijs.12427, PubMed 25580572

Hornslien AG, Sandset EC, Igland J, Terént A, Boysen G, Bath PM, Murray GD, Berge E (2015)
Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)
Int J Stroke, 10 (6), 830-5
DOI 10.1111/ijs.12477, PubMed 25808741

Hornslien AG, Sandset EC, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2015)
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
J Hypertens, 33 (7), 1487-91
DOI 10.1097/HJH.0000000000000581, PubMed 26039534

Kakaletsis N, Ntaios G, Milionis H, Haidich AB, Makaritsis K, Savopoulos C, Berge E, Hatzitolios AI (2015)
Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis
Int J Stroke, 10 (7), 1000-7
DOI 10.1111/ijs.12609, PubMed 26283262

Kjeldsen SE, Berge E (2015)
Blood pressure and early neurological deterioration in acute ischemic stroke
J Hypertens, 33 (10), 2020-1
DOI 10.1097/HJH.0000000000000689, PubMed 26431189

Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S (2015)
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial
Blood Press, 25 (2), 83-92
DOI 10.3109/08037051.2015.1106750, PubMed 26511535

Krishnan K, Scutt P, Woodhouse L, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V, Chen C, Christensen H, Collins R, Czlonkowska A, Dineen RA, Gommans J, Koumellis P, Lees KR, Ntaios G, Ozturk S, Phillips SJ, Pocock SJ, de Silva A, Sprigg N, Szatmari S, Wardlaw JM et al. (2015)
Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis
Stroke, 47 (1), 44-52
DOI 10.1161/STROKEAHA.115.010368, PubMed 26645254

Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
Stroke, 46 (3), 877-9
DOI 10.1161/STROKEAHA.114.008512, PubMed 25657183

Seiffge DJ, Hooff RJ, Nolte CH, Béjot Y, Turc G, Ikenberg B, Berge E, Persike M, Dequatre-Ponchelle N, Strbian D, Pfeilschifter W, Zini A, Tveiten A, Næss H, Michel P, Sztajzel R, Luft A, Gensicke H, Traenka C, Hert L, Scheitz JF, De Marchis GM, Bonati LH, Peters N, Charidimou A et al. (2015)
Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome
Circulation, 132 (13), 1261-9
DOI 10.1161/CIRCULATIONAHA.115.015484, PubMed 26232277

Wardlaw J, Berge E (2015)
Cochrane reviewers' response to Alper and colleagues' analysis of thrombolysis in acute ischaemic stroke
BMJ, 350, h1790
DOI 10.1136/bmj.h1790, PubMed 25850827

Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G, Wardlaw J, Sprigg N, Bath PM, ENOS Investigators (2015)
Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial
Stroke, 46 (11), 3194-201
DOI 10.1161/STROKEAHA.115.009647, PubMed 26463698

Publications 2014

Arauz A, Berge E, Sandercock P (2014)
Third International Stroke Trial 3: an update
Curr Opin Neurol, 27 (1), 8-12
DOI 10.1097/WCO.0000000000000045, PubMed 24241447

Berge E (2014)
Can we agree on a standard terminology for catheter-based interventions for acute ischemic stroke?
Stroke, 45 (3), e42
DOI 10.1161/STROKEAHA.113.004668, PubMed 24473181

Bruins Slot KM, Berge E (2014)
Factor Xa inhibitors vs warfarin for preventing stroke and thromboembolism in patients with atrial fibrillation
JAMA, 311 (11), 1150-1
DOI 10.1001/jama.2014.1403, PubMed 24643605

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke
Stroke, 45 (11), 3440-2
DOI 10.1161/STROKEAHA.114.006433, PubMed 25256183

Jusufovic M, Sandset EC, Bath PM, Karlson BW, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis
Int J Stroke, 10 (3), 354-9
DOI 10.1111/ijs.12418, PubMed 25472578

Jusufovic M, Sandset EC, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Response to letter regarding article, "Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke"
Stroke, 46 (1), e14
DOI 10.1161/STROKEAHA.114.007859, PubMed 25492909

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
DOI 10.1378/chest.13-2828, PubMed 25180723

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Flem Jacobsen A, Granan LP, Halvorsen S, Guyatt G, Vandvik PO (2014)
Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest, 146 (3), 735-761
DOI 10.1378/chest.13-2993, PubMed 25180724

Kristiansen A, Brandt L, Berge E, Dahm AE, Halvorsen S, Sandset PM, Vandvik PO (2014)
[New guidelines for antithrombotic therapy and thromboprophylaxis]
Tidsskr Nor Laegeforen, 134 (9), 921-2
DOI 10.4045/tidsskr.13.1582, PubMed 24828713

Sandset EC, Berge E, Kjeldsen SE, Julius S, Holzhauer B, Krarup LH, Hua TA (2014)
Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack
J Stroke Cerebrovasc Dis, 23 (10), 2814-2818
DOI 10.1016/j.jstrokecerebrovasdis.2014.07.009, PubMed 25304725

Tveit A, Halvorsen S, Berge E, Sætre T (2014)
[Antithrombotic treatment in atrial fibrillation and cardiovascular disease]
Tidsskr Nor Laegeforen, 134 (9), 923
DOI 10.4045/tidsskr.13.1618, PubMed 24828714

Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2014)
Thrombolysis for acute ischaemic stroke
Cochrane Database Syst Rev (7), CD000213
DOI 10.1002/14651858.CD000213.pub3, PubMed 25072528

Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2014)
Thrombolysis for Acute Ischemic Stroke, Update August 2014
Stroke, 45 (11), E222-E225

Wardlaw JM, Murray V, Berge E, Del Zoppo GJ (2014)
Alteplase for ischaemic stroke--responses
Lancet, 384 (9944), 661-2
DOI 10.1016/S0140-6736(14)61387-8, PubMed 25152267

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z et al. (2014)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial
J Hypertens, 32 (9), 1888-97
DOI 10.1097/HJH.0000000000000254, PubMed 24979303

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z et al. (2014)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence
J Hypertens, 32 (9), 1741-50
DOI 10.1097/HJH.0000000000000253, PubMed 24979302

Publications 2013

Bruins Slot KM, Berge E (2013)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev (8), CD008980
DOI 10.1002/14651858.CD008980.pub2, PubMed 23925867

Hornslien AG, Sandset EC, Bath PM, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2013)
Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial
Stroke, 44 (7), 2022-4
DOI 10.1161/STROKEAHA.113.001022, PubMed 23660849

Slot KMHB, Berge E (2013)
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Stroke, 44 (12), E165-E167

Sprigg N, Selby J, Fox L, Berge E, Whynes D, Bath PM, Efficacy of Nitric Oxide in Stroke Investigators (2013)
Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial
Stroke, 44 (12), 3458-62
DOI 10.1161/STROKEAHA.113.002201, PubMed 24149005

van der Hoeven EJ, Schonewille WJ, Vos JA, Algra A, Audebert HJ, Berge E, Ciccone A, Mazighi M, Michel P, Muir KW, Obach V, Puetz V, Wijman CA, Zini A, Kappelle JL, BASICS Study Group (2013)
The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial
Trials, 14, 200
DOI 10.1186/1745-6215-14-200, PubMed 23835026

Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
Lancet Neurol, 12 (6), 539-45
DOI 10.1016/S1474-4422(13)70079-6, PubMed 23642343

Publications 2012

Ankolekar S, Renton C, Bereczki D, Sprigg N, Payne T, Gommans J, Berge E, Wardlaw J, Dennis MS, Bath PM, ENOS Trial Investigators (2012)
Effect of the neutral CLOTS 1 trial on the use of graduated compression stockings in the Efficacy of Nitric Oxide Stroke (ENOS) trial
J Neurol Neurosurg Psychiatry, 84 (3), 342-7
DOI 10.1136/jnnp-2012-303396, PubMed 23117488

Berge E (2012)
Can angiotensin-converting enzyme inhibitors reduce the risk of pneumonia after stroke?
J Hypertens, 30 (11), 2088-9
DOI 10.1097/HJH.0b013e328358bb10, PubMed 23052047

Cruz-Flores S, Berge E, Whittle IR (2012)
Surgical decompression for cerebral oedema in acute ischaemic stroke
Cochrane Database Syst Rev, 1, CD003435
DOI 10.1002/14651858.CD003435.pub2, PubMed 22258954

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Lancet, 379 (9834), 2352-63
DOI 10.1016/S0140-6736(12)60768-5, PubMed 22632908

Nilsen KB, Berg-Hansen P, Berge E, Petterson MA, Gjesdal K (2012)
[A man with debilitating orthostatic hypotension]
Tidsskr Nor Laegeforen, 132 (15), 1758-61
DOI 10.4045/tidsskr.11.1360, PubMed 22929944

Sandset EC, Berge E (2012)
Response to Letter by Simone Vidale Regarding Article, "Relation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome"
Stroke, 43 (12), E177

Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
Stroke, 43 (8), 2108-14
DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991

Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G (2012)
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
Lancet, 379 (9834), 2364-72
DOI 10.1016/S0140-6736(12)60738-7, PubMed 22632907

Whynes DK, Sprigg N, Selby J, Berge E, Bath PM, ENOS Investigators (2012)
Testing for differential item functioning within the EQ-5D
Med Decis Making, 33 (2), 252-60
DOI 10.1177/0272989X12465016, PubMed 23184462

Publications 2011

Berge E (2011)
Should high blood pressure be lowered in the acute stroke?
J Hypertens, 29 (8), 1478-9
DOI 10.1097/HJH.0b013e32834a019b, PubMed 21750435

O'Rourke K, Berge E, Kelly PJ (2011)
Response to Letter by Papanagiotou et al Regarding Article, "Percutaneous Vascular Interventions for Acute Ischemic Stroke"
Stroke, 42 (9), E546

O'Rourke K, Berge E, Walsh C, Kelly PJ (2011)
Percutaneous Vascular Interventions for Acute Ischemic Stroke
Stroke, 42 (3), E31-E32

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
Trials, 12, 252
DOI 10.1186/1745-6215-12-252, PubMed 22129158

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Lancet, 377 (9767), 741-50
DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752

Publications 2010

Krarup LH, Sandset EC, Sandset PM, Berge E (2010)
D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
Acta Neurol Scand, 124 (1), 40-4
DOI 10.1111/j.1600-0404.2010.01409.x, PubMed 20726843

O'Rourke K, Berge E, Walsh CD, Kelly PJ (2010)
Percutaneous vascular interventions for acute ischaemic stroke
Cochrane Database Syst Rev (10), CD007574
DOI 10.1002/14651858.CD007574.pub2, PubMed 20927761

Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
Int J Stroke, 5 (5), 423-7
DOI 10.1111/j.1747-4949.2010.00473.x, PubMed 20854630

Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2010)
Thrombolysis for Acute Ischemic Stroke
Stroke, 41 (6), E445-E446

Publications 2009

Slot KB, Berge E (2009)
Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement
J Stroke Cerebrovasc Dis, 18 (1), 17-22
DOI 10.1016/j.jstrokecerebrovasdis.2008.06.009, PubMed 19110139

Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M, Oxfordshire Community Stroke Project, Lothian Stroke Register, International Stroke Trial (UK) (2009)
Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts
Stroke, 40 (5), 1585-9
DOI 10.1161/STROKEAHA.108.531533, PubMed 19265057

Wardlaw JM, Murray V, Berge E, Del Zoppo GJ (2009)
Thrombolysis for acute ischaemic stroke
Cochrane Database Syst Rev (4), CD000213
DOI 10.1002/14651858.CD000213.pub2, PubMed 19821269

Publications 2008

Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P et al. (2008)
Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
Trials, 9, 37
DOI 10.1186/1745-6215-9-37, PubMed 18559104

Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
EPITHET--where next?
Lancet Neurol, 7 (7), 570-1; author reply 571-3
DOI 10.1016/S1474-4422(08)70123-6, PubMed 18565447

Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, Oxfordshire Community Stroke Project, the International Stroke Trial (UK), Lothian Stroke Register (2008)
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
BMJ, 336 (7640), 376-9
DOI 10.1136/bmj.39456.688333.BE, PubMed 18230644

Slot KB, Berge E, Wardlaw J (2008)
Haemorrhagic transformation of a recent silent cerebral infarct during thrombolytic stroke treatment
BMJ Case Rep, 2008, bcr0620080266
DOI 10.1136/bcr.06.2008.0266, PubMed 21716819

Publications 2007

Berge E (2007)
Decompressive surgery for cerebral oedema after stroke: evidence at last
Lancet Neurol, 6 (3), 200-1
DOI 10.1016/S1474-4422(07)70039-X, PubMed 17303520

Berge E (2007)
Heparin for acute ischaemic stroke: a never-ending story?
Lancet Neurol, 6 (5), 381-2
DOI 10.1016/S1474-4422(07)70087-X, PubMed 17434083

Berge E, Dahl T (2007)
[Heart disease and stroke]
Tidsskr Nor Laegeforen, 127 (7), 897-9
PubMed 17435813

Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
Stroke, 38 (3), 1069-71
DOI 10.1161/01.STR.0000258076.04860.8e, PubMed 17290027

Publications 2006

O'Donnell MJ, Berge E, Sandset PM (2006)
Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
Stroke, 37 (2), 452-5
DOI 10.1161/01.STR.0000198887.81948.74, PubMed 16410483

Publications 2004

Murray V, Berge E, Sandercock P, Norrving B, Wester P, Terént A (2004)
The need to recognize the difference between a quality register and a randomized controlled trial
Stroke, 35 (11), 2431-2
DOI 10.1161/01.STR.0000144687.45236.a0, PubMed 15472093

Russell D, Thomassen L, Indredavik B, Sandset PM, Joakimsen O, Berge E (2004)
[Patients with acute brain infarction should receive thrombolytic therapy]
Tidsskr Nor Laegeforen, 124 (12), 1666-7
PubMed 15229721

Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Wardlaw J (2004)
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs
Stroke, 35 (6), 1490-7
DOI 10.1161/01.STR.0000126871.98801.6E, PubMed 15105519

Publications 2003

Berge E, Sandercock P (2003)
Anticoagulants for acute ischemic stroke
Adv Neurol, 92, 257-62
PubMed 12760191

Hankey GJ, Berge E, Sandercock P (2003)
Anticoagulants versus antiplatelet agents for acute ischemic stroke
Stroke, 34 (6), 1571-2
DOI 10.1161/01.STR.0000074551.42683.98, PubMed 12764231

Morley NC, Berge E, Cruz-Flores S, Whittle IR (2003)
Surgical decompression for cerebral edema in acute ischemic stroke
Stroke, 34 (5), 1337
DOI 10.1161/01.STR.0000069264.00152.A1, PubMed 12690210

Publications 2002

Berge E, Barer D (2002)
Could stroke trials be missing important treatment effects?
Cerebrovasc Dis, 13 (1), 73-5
DOI 10.1159/000047752, PubMed 11810016